UPDATE: Morgan Stanley Starts Instil Bio Inc (TIL) at Equalweight

April 13, 2021 3:41 AM EDT
Get Alerts TIL Hot Sheet
Price: $18.95 +3.05%

Rating Summary:
    3 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 38 | Down: 18 | New: 7
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
(Updated - April 13, 2021 5:14 AM EDT)

Morgan Stanley analyst Vikram Purohit initiates coverage on Instil Bio Inc (NASDAQ: TIL) with a Equalweight rating and a price target of $24.00.

The analyst comments "Instil Bio's lead TIL product candidate ITIL-168 has generated encouraging early clinical data, and we estimate the therapy could generate $1B+ in risk-adjusted sales in melanoma. However, we believe current levels imply appropriate value for ITIL-168, and we await further clinical data updates."

For an analyst ratings summary and ratings history on Instil Bio Inc click here. For more ratings news on Instil Bio Inc click here.

Shares of Instil Bio Inc closed at $21.94 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities

Morgan Stanley